Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Showing posts with label hospital incompetence?. Show all posts
Showing posts with label hospital incompetence?. Show all posts

Thursday, September 10, 2026

The Effect of Robot-Assisted Gait Training on Balance, Gait and Kinesiophobia in Individuals With Post-Stroke Hemiparesis: A Randomized Controlled Trial

 Get mental help if you think this will ever reach your hospital, they haven't even gotten music therapy installed! HOW MUCH MORE FUCKING INCOMPETENCE DO YOU NEED DISPLAYED BEFORE YOU REALIZE YOUR STROKE HOSPITAL DOESN'T KNOW ANYTHING ABOUT 100% STROKE RECOVERY?

The Effect of Robot-Assisted Gait Training on Balance, Gait and Kinesiophobia in Individuals With Post-Stroke Hemiparesis: A Randomized Controlled Trial


ABSTRACT

Background and Purpose

Robot-assisted gait training (RAGT) is well established for post-stroke gait rehabilitation, but its potential effects on psychological and behavioral outcomes are less clear. This study investigated the effects of adding RAGT to conventional rehabilitation on balance, gait, kinesiophobia, and movement confidence in individuals with post-stroke hemiparesis.

Methods

This single-blind, parallel-group randomized controlled trial included 60 individuals with post-stroke hemiparesis (50–75 years), randomly allocated to an RAGT group (n = 30) or control group (n = 30). Ethical approval was obtained from the Clinical Research Ethics Committee of Istanbul Yeni Yüzyıl University (Approval No. 20.01.2022/05; approval date: 20 January 2022). Both groups received conventional rehabilitation for 8 weeks; the RAGT group additionally received 24 sessions of RAGT. Kinesiophobia was a prespecified study outcome assessed using the Kinesiophobia Causes Scale (KCS); balance, gait, and balance confidence were also assessed. All 60 randomized participants completed follow-up and were analyzed in their assigned groups.

Results

Significant group × time interactions were observed for several outcomes, including BBS, TUG duration, 10MWT walking speed, ABC, and KCS total score (p < 0.05). The between-group difference in change for KCS total score was −0.36 (95% CI: −0.51 to −0.21; partial eta squared = 0.292). In post hoc analyses adjusting each outcome for its baseline value, significant group effects remained for BBS, TUG duration, 10MWT walking speed, ABC, KCS biological domain, and KCS total score (p< = 0.031), whereas 10MWT step count and the KCS psychological domain were no longer statistically significant.

Discussion

Adding RAGT to conventional rehabilitation was associated with greater improvements in several balance, mobility, walking-speed, balance-confidence, and kinesiophobia outcomes compared with conventional rehabilitation alone. These findings suggest potential additional physical and psychological benefits of incorporating RAGT into post-stroke rehabilitation. However, because the RAGT group received greater overall treatment exposure, the observed between-group differences cannot be attributed solely to the robotic component. The principal contribution of this study is the concurrent evaluation of kinesiophobia and movement confidence alongside physical outcomes.

Conflicts of Interest

The authors declare that they have no financial, commercial, personal, or institutional relationships that could have influenced this work. The RoboGait device was already available as part of routine clinical practice and was not provided, loaned, or funded by BAMA Technology or its distributor for this study. Neither the manufacturer nor any distributor had any role in study design, participant recruitment, data collection, analysis, interpretation, manuscript preparation, or the decision to submit the manuscript. The authors have no commercial, financial, or institutional affiliation with the manufacturer or distributor.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request. Due to ethical restrictions related to patient confidentiality, the data are not publicly available.

Wednesday, September 9, 2026

Effects of an actuated ankle exoskeleton on walking stability in healthy adults: a controlled laboratory study

 Do your competent? doctors and hospital have enough brains to get this tested in stroke survivors? 

NO? So, PURE INCOMPETENCE!

Effects of an actuated ankle exoskeleton on walking stability in healthy adults: a controlled laboratory study

    Abstract

    Background

    Ankle exoskeletons are widely used to reduce the metabolic cost of walking, yet their effects on walking stability during unperturbed gait remain insufficiently understood. Walking stability can be characterized using complementary measures that capture stride-to-stride variability, global temporal organization, and local dynamic stability. Understanding how walking with an actuated ankle exoskeleton system influences these different aspects of gait stability is essential for the safe design and control of wearable robotic devices.

    Methods

    Eighteen healthy adults walked on a treadmill at a constant speed (1.1 m/s) with and without an actuated bilateral ankle exoskeleton in a randomized crossover design. Spatiotemporal variability was quantified using coefficients of variation (CoV) of stride length, step width, and stance ratio. Global gait stability was assessed using detrended fluctuation analysis of stride time. Local dynamic stability was evaluated using maximum Lyapunov exponent calculated for the trunk, hip, upper leg, lower leg, and foot. Paired-samples two-sided t-tests were used to compare conditions.

    Results

    Walking with the ankle exoskeleton resulted in increased stride-to-stride spatiotemporal variability, reflected by higher CoV values for stride length (p < 0.001) and stance ratio (p = 0.005), while mean stride length and step width remained unchanged. Mean stance ratio was reduced in the exoskeleton condition (p < 0.001). Global gait stability did not differ between conditions, indicating preserved long-range temporal gait organization. Local dynamic stability increased at the lower leg (p < 0.001) and foot (p = 0.019) when walking with the exoskeleton.

    Conclusions

    Walking with the actuated ankle exoskeleton alters gait control across multiple levels during steady walking. While stride-to-stride variability in stride length and stance ratio increased, global gait stability remained unchanged. Local dynamic stability was increased at the lower leg and foot, suggesting segment-specific effects of ankle-level assistance close to the assisted joint. However, these findings should be interpreted as the combined effect of wearing the exoskeleton and receiving active assistance, rather than the isolated effect of plantarflexion assistance. These results provide insight for the design and control of ankle exoskeletons with respect to stability-related effects during walking.

    Monday, September 7, 2026

    ENTF Neuromodulation Yields Reduced Disability After Stroke: An Individual Participant-Level Data Meta-Analysis

     Acknowledging A COMPLETE FUCKING FAILURE by not getting to 100% recovery! For that tyranny of low expectations; you're all fired! Even rock star stroke researchers like Steven C. Cramer aren't getting this right!

    Let's check how long your doctor and hospital have been incompetent in not having ENTF!

    • ENTF (6 posts to October 2025) Almost a year and those involved should be keel hauled!

    ENTF Neuromodulation Yields Reduced Disability After Stroke: An Individual Participant-Level Data Meta-Analysis


    Abstract

    BACKGROUND:

    Electromagnetic network-targeted field (ENTF) brain stimulation therapy is a promising approach to reduce poststroke disability. Two pilot, randomized, sham-controlled trials showed safety and signals of efficacy. The aim of this study was to perform a pooled analysis with greater statistical power to characterize with precision the effect of ENTF in promoting recovery and reducing disability.

    METHODS:

    We pooled individual patient-level data from 2 double-blind, randomized, sham-controlled studies, BQ3 (BrainQ3 Trial; Unique identifier: NCT04039178) and EMAGINE 1 (Electromagnetic Field Ischemic Stroke-Novel Subacute Treatment Trial; NCT05044507). Key entry criteria in both trials were (1) 4 to 21 days post-ischemic stroke and (2) Fugl-Meyer assessment-upper extremity score of 10 to 45. For EMAGINE 1, an additional criterion was a study entry modified Rankin Scale (mRS) score of 3 to 4. The primary outcome for this pooled analysis was freedom-from-disability (mRS score, 0–1) at 8 to 12 weeks. Secondary outcomes were level of disability (ordinal mRS score distribution), disability change (delta mRS score) change from entry to 8 to 12 weeks, and 2 focused upper extremity motor end points.

    RESULTS:

    Altogether, 124 patients were included (active n=65; sham n=59). The mean age was 58.2±13.1 years, 31% were female, the study entry Fugl-Meyer assessment-upper extremity score was 25.3 (±10.6), and the therapy started 14.5 (±4.9) days poststroke. The study entry mRS score was 3.9 (±0.36), and 123/124 (99.2%) had a study entry mRS score of 3 to 4. Study entry features were well-balanced across treatment groups. At 8 to 12 weeks, freedom-from-disability was higher with active ENTF than sham stimulation (33.8% versus 11.9%; P=0.005). Ordinal shift across 3 disability strata (mRS score, 0–1, 2, and >2) also favored ENTF (P=0.009). Focused upper extremity motor end points nonsignificantly favored ENTF. Safety analyses showed no device- or procedure-related serious adverse events.

    CONCLUSIONS:

    In pooled data from 2 randomized, sham-controlled trials, treatment with ENTF compared with sham for patients with subacute ischemic stroke with moderate-severe study entry disability yielded increased(NOT RECOVERY!) achieved freedom-from-disability, greater disability improvement from study entry, and reduced(NOT RECOVERY!)final disability level. These findings, together with an attractive safety profile, support ENTF as a promising therapy for stroke recovery.(Which means you are accepting failure as Ok; survivors don't accept that!)

    Graphical Abstract

    Get full access to this article

    Healthy aging: Training the mind and emotional skills helps keep the brain healthy

     Does your competent? doctor have EXACT PROTOCOLS to restore the cognitive reserve you lost because of your stroke? Doesn't even know of the need? 

    PURE INCOMPETENCE!

    Healthy aging: Training the mind and emotional skills helps keep the brain healthy



    Two studies from SISSA show that cognitive reserve built over a lifetime, together with emotional resources, helps preserve mental abilities in adults over 65

    Peer-Reviewed Publication

    Scuola Internazionale Superiore di Studi Avanzati, intellectually stimulating work, and an active lifestyle help preserve cognitive abilities in adults over 65, leading to more effective verbal expression and stronger cognitive performance. But there is another important factor: emotions. The way we recognize and interpret them can significantly influence the efficiency of cognitive processes as we age.

    These findings emerge from two new studies conducted by the laboratory of Professor Raffaella Rumiati at theScuola Internazionale Superiori di Studi Avanzati (SISSA) in Trieste, Italy, recently published in Neuropsychology and Brain Sciences. The researchers examined how a group of adults over the age of 65 performed on various tasks to identify factors that help preserve cognitive function later in life.

    The first authors of the two studies, Elisabetta Pisanu and Stefania Lucia, focused in particular on the role of cognitive reserve—the set of mental resources accumulated throughout life through education, professional experience, and intellectually engaging leisure activities. The first study found that individuals with greater cognitive reserve performed better in language tasks, showing a greater ability to express themselves and retrieve the right words. Positive emotions also contributed to better language performance.

    The second study showed that cognitive reserve also plays a key role in supporting working memory—the ability to temporarily retain, process, and use information to complete a task. Emotions also influence these cognitive processes: they not only improve performance, but also shape the way we respond to different stimuli. In particular, higher emotional intelligence, i.e. the ability to recognize, understand, and use emotions to guide thinking, behaviour, and relationships, was found to significantly influence participants' responses to emotional stimuli.

    Overall, the findings confirm that an intellectually stimulating life helps preserve cognitive function as we grow older. They also suggest that cognitive and emotional resources do not operate independently but work together to support healthier and more efficient cognitive ageing. Both studies were carried out as part of Age-It: Ageing Well in an Ageing Society, a major Italian research programme investigating the challenges and opportunities associated with population ageing.

    Finding the right words: Cognitive reserve and emotions shape language in later life

    Cognitive reserve helps preserve language abilities as we age. The study published in Neuropsychology found that older adults with greater cognitive reserve maintained better language performance than their peers.

    “Our findings show that older adults with higher cognitive reserve achieve language performance comparable to that of younger adults,” explains Elisabetta Pisanu, first author of the study. “In our experiments, we focused on what happens during the first ten seconds of a verbal fluency task, when people search for the right words to express their thoughts. This brief time window captures the fastest and most automatic processes involved in word retrieval, without the need for the traditional one-minute test. We found that these first ten seconds are already sufficient to reveal the effects of both ageing and cognitive reserve on language performance.”

    The researchers observed that a decline in performance is already detectable during these initial moments in adults over 65. However, this decline is greatly reduced, and may even disappear, in individuals with high cognitive reserve. “In other words,” the researchers explain, “cognitive reserve helps keep the brain ‘young’, at least when it comes to language and word retrieval.”

    The study also found that not all words are equally easy to retrieve. According to Pisanu: “Older adults retrieve words associated with positive emotions more easily than those linked to negative emotions. These findings suggest that, alongside the protective role of cognitive reserve, the emotional valence of words also contributes to language performance.”

    Ageing and working memory: Experience and emotions support cognition in different ways

    As we grow older, working memory—the ability to temporarily hold, process, and use information to complete a task—also tends to become less efficient. The study published in Brain Sciences investigated how cognitive reserve and emotional intelligence contribute to working memory, particularly when emotions are relevant to the task at hand.

    To address this question, the researchers asked a group of adults over the age of 65 to complete a working memory task in which, depending on the condition, they had to focus either on the emotional expression or on the age of the faces presented to them. “We wanted to understand whether cognitive reserve and emotional intelligence play different roles depending on whether emotions are relevant—or irrelevant—to a working memory task,” explains Stefania Lucia, first author of the study.

    The findings showed that cognitive reserve improves performance regardless of the type of task. “Our results indicate that cognitive reserve enhances performance accuracy independently of the experimental condition,” says Lucia. “This suggests that it plays a fundamental role in supporting the ability to maintain and manipulate the information needed to carry out a task.” The role of emotions also emerged clearly. “When the task involves emotional content, older adults perform better: they appear to become more efficient,” Lucia observes. Emotional intelligence, in turn, influences the way people process information and respond to the task.

    “It affects how individuals process information and generate a response, ultimately shaping their performance. For example, people with higher emotional intelligence take longer to respond to emotional stimuli, probably because they devote greater attentional and cognitive resources to processing them. This does not reflect greater difficulty, but rather deeper and more thorough processing of emotional information.”

    Raffaella Rumiati: Understanding cognitive ageing is a scientific and societal challenge

    “Both of these studies were carried out as part of Age-It: Ageing Well in an Ageing Society, an ambitious national research programme that has laid the foundations for a research and data infrastructure dedicated to the study of ageing from multiple perspectives, including socio-economic, biomedical, and technological dimensions,” says Raffaella Rumiati, neuroscientist at SISSA and principal investigator of both studies.

    “Italy is one of the world's longest-lived countries, together with Japan. While this is an extraordinary achievement, it also brings new challenges. As the older population continues to grow, so does the demand for healthcare and long-term care services. Understanding how to preserve cognitive abilities for as long as possible is therefore essential—not only to improve people's quality of life, but also to help ensure the sustainability of healthcare and social welfare systems.” According to Rumiati, cognitive decline and the strategies to counteract it are among the major challenges of an ageing society.“Our research can contribute in two important ways: by improving the methodological tools used to study cognitive ageing, and by identifying the factors that help protect cognitive functions as people grow older.”

    She concludes: “Our findings show that an intellectually stimulating life helps preserve a wide range of cognitive functions, from language to working memory. They also highlight the important role of emotions, which, as our studies suggest, make a significant contribution to the efficiency of cognitive processes. Taken together, these findings indicate that cognitive reserve and emotional skills contribute to healthier and more efficient cognitive ageing. These are promising results that we intend to explore further in future studies.”

    Sunday, September 6, 2026

    New injectable treatment helps the brain rebuild after stroke

     Have your competent? doctor and hospital ensure that human testing occurs and EXACT PROTOCOLS ARE CREATED!  

    Not doing so IS PURE INCOMPETENCE!

    New injectable treatment helps the brain rebuild after stroke

    Date:
    September 3, 2026
    Source:
    Duke University
    Summary:
    Duke researchers developed an injectable scaffold that helped stroke-damaged brains grow new blood vessels, support nerve regrowth, and recover movement in mice. The treatment appears to work partly by recruiting the body’s own immune cells, including neutrophils that may switch from damaging to helpful under the right conditions.

    Thursday, September 3, 2026

    This Is What Happened When People Ran At A Surprisingly Easy Pace by mindbodygreen

     Did your incompetent? doctor have ANYTHING  that would get you running again? I'd need my spasticity cured! I bet your doctor didn't even ask you if you wanted to run again, THAT IS HOW FUCKING INCOMPETENT S/HE IS!

    Maybe something from this book?

    Tommye-K. Mayer book; 'Teaching Me to Run'.

    Do you prefer your doctor, hospital and board of director's incompetence NOT KNOWING? OR NOT DOING? Your choice; let them be incompetent or demand action!

    This Is What Happened When People Ran At A Surprisingly Easy Pace

    Wednesday, September 2, 2026

    8 of the Best Drinks to Support Healthy Aging, According to Nutritionists

     I'm sure your incompetent? hospital doesn't have most of these and for sure; NO PROTOCOLS!

    8 of the Best Drinks to Support Healthy Aging, According to Nutritionists

     While a well-balanced diet and frequent exercise are often emphasized in discussions about healthy aging, the fluids you drink are just as important. Many beverages are marketed as “good for you,” but they often contain added sugar and fall short on their promises.

    To find out which drinks actually support healthy aging, we spoke to registered dietitians. Here, they share some of the best options to include in your diet. Some may surprise you, while others might already be a staple in your daily routine.

    • Adiana Castro, MS, RDN, CLT, New York City-based metabolic dietitian, founder of Compass Nutrition 
    • Shelley Balls, a registered dietitian from Flawless Bloom

    Kefir

    Probiotics are a vital part of a balanced gut microbiome.1 Kefir, a fermented milk product, is a probiotic powerhouse. It can feature many dozens of 60 strains of bacteria and yeast that promote a healthier microbiome for our gut. “As we age, gut health can play a huge part in disease prevention, immunity, and even mental health,” says Shelley Balls, a registered dietitian from Flawless Bloom.2

    If you’re looking to add Kefir to your daily routine, Adiana Castro, a New York City-based metabolic dietitian and founder of Compass Nutrition, recommends choosing the plain version at the grocery store and making sure the label includes information about live and active cultures for maximum health benefits. “I would recommend drinking 4 to 8 ounces of kefir every day. Start with 2 ounces per day and then work your way up to 4 to 8 ounces per day,” says Castro.

    Bone Broth

    If you enjoy the savory flavors of chicken broth, try incorporating 3 to 4 cups of bone broth into your wellness routine each week. It’s a warm drink that is packed with nutrients to help support the function of the intestinal barrier, says Castro.3 It’s rich in amino acids such as glutamine, glycine, proline, histidine, arginine, as well as minerals including calcium, phosphorus, potassium, magnesium, and zinc. Getting enough minerals is essential to maintaining bone strength.

    “Glutamine is especially helpful in reducing inflammation,” says Castro. The gelatin in bone broth helps repair the gut lining, improving absorption, which is crucial as digestion capacity decreases with age.3

    In addition to promoting bone and gut health, bone broth can also benefit the skin.4 It contains a significant amount of collagen, which helps with skin elasticity. When buying bone broth, check the label to see if it has been simmered for at least eight hours; “the levels of nutrients released from the bones are higher with longer cooking times,” says Castro.

    Herbal Tea

    Getting enough sleep each night supports healthy aging, and herbal tea can help.5 These teas are rich in plant compounds such as polyphenols and flavonoids, which protect cells from oxidative stress, which accelerates the aging process. “Chamomile or lemon balm can help with restful sleep and stress reduction, which are both crucial for aging well.6 I recommend 1 cup of any flavor of herbal tea daily,” says Castro.



    Coffee

    Coffee is rich in antioxidants, which have protective effects on our health with respect to Alzheimer’s and Parkinson’s diseases. “There is increasing evidence in favor of protective effects of coffee consumption in the development and progression of liver disease. Caffeine may stimulate liver enzymes and improve liver function,” says Castro.7

    She also notes that the recommended daily coffee intake varies by individual, but the average tolerance is two to four cups per day before 2:00 p.m. To ensure that your body properly absorbs the benefits, it’s best to consume coffee at least one hour before mealtime, according to Balls. “If possible, it’s best to eat breakfast first, then drink it after breakfast, so you’re not consuming coffee on an empty stomach, which can irritate your stomach lining,” says Balls.

    While drinking coffee has health benefits, it’s essential to note that adding excessive sugar, cream, or flavored syrups can negate these benefits.

    Green Tea

    Green tea comes from the Camellia sinensis plant and is brewed at a lower temperature, resulting in a lighter, fresher flavor. “It is rich in the polyphenol EGCG, which acts like a powerful antioxidant that helps reduce oxidative stress and inflammation, both of which greatly impact aging,” says Castro.8 Green tea helps balance blood sugar, which is also important for longevity.

    If you choose to drink green tea daily, Castro recommends 2 to 3 cups, steeped for about 2 to 3 minutes, consumed before 2:00 p.m. to maximize health benefits and ensure good sleep.

    Black Tea

    Like green tea, black tea is made from the Camellia sinensis plant but is brewed at a higher temperature and has a more bitter taste. Black tea contains polyphenols, such as theaflavins and thearubigins, that act like prebiotics, benefiting the bacteria in your microbiome.

    “These polyphenols feed keystone strains like Bifidobacteria and Lactobacillus that support the immune system as you age. I recommend up to 1-2 cups of black tea daily, steeped for about 4-5 minutes before 2:00 PM to avoid sleep disruption,” says Castro.9

    Water

    Incorporating even one of these drinks into your weekly wellness routine can support healthy aging. But drinking enough water each day is essential. “Sure, it doesn’t have a lot of bells or whistles, but water is such an important part of your body, and can help manage blood sugar levels if you’re adequately hydrated,” says Balls. “Staying hydrated with water helps lower your risk of heart disease, kidney stones, and diabetes, which are common concerns as we age.”101112

    If plain water is hard to drink in large amounts, Castro recommends adding flavor without artificial sweeteners:

    • Infuse with fruit: Slice citrus, berries, or cucumbers to give your water a natural flavor boost.

    • Freeze flavored ice cubes: Make ice cubes from herbal tea or pureed fruit and drop them into your water for a burst of flavor as they melt.

    • Balance caffeine with water: Drink a glass of water for every cup of coffee, tea, or energy drink.

    • Set reminders: If you often forget to hydrate, set gentle phone reminders for water breaks and pay attention to your body’s thirst and dehydration signals.

    Instead of relying on caffeinated drinks throughout the day, check in with yourself to be sure you’re drinking enough water. Staying hydrated supports energy levels, which can motivate you to be active and maintain healthy habits, says Balls. “Your hydration status is also linked to your metabolic health, crucial for fat metabolism, nutrient transport, and waste removal.”

    Martha’s Green Juice

    And of course, we can’t forget Martha’s green juice. For years, she has credited her prized green juice for contributing to her good health. “This is what I recharge my batteries with every single morning,” she says. “I don’t leave my house without it.”

    Her recipe includes pears, celery, cucumbers, parsley, ginger, and orange. While juice lacks the fiber of whole fruits and vegetables, green juice is a health-boosting blend that makes it easy to drink your greens. If certain ingredients are low in supply or out of season, simply swap them for other nutritious vegetables and fruits you like. Note that we are referring to juice fresh-pressed at home, which doesn’t include the sweeteners or other additives you might find in bottled versions. 

    HEPA Air Purifiers May Enhance Cognitive Function After Just One Month: Study

     This should IMMEDIATELY get your incompetent? hospital to install them in stroke patients rooms! But nothing will happen, incompetence has too much inertia to be budged!

    HEPA Air Purifiers May Enhance Cognitive Function After Just One Month: Study

    Nanoparticles regenerate neurons and improve cognition in Alzheimer’s mice

    Will your competent? doctor and hospital get followup research initiated that will create protocols that prevent Alzheimers or be used in recovering from a stroke?

    Do you prefer your doctor, hospital and board of director's incompetence NOT KNOWING? OR NOT DOING? Your choice; let them be incompetent or demand action!

    Your doctor is responsible for preventing this! Is s/he willing to prevent this?

    1. A documented 33% dementia chance post-stroke from an Australian study?   May 2012.

    2. Then this study came out and seems to have a range from 17-66%. December 2013.`    

    3. A 20% chance in this research.   July 2013.

    4. Dementia Risk Doubled in Patients Following Stroke September 2018 

    The latest here:

     Nanoparticles regenerate neurons and improve cognition in Alzheimer’s mice

    The adult human brain has limited capacity to repair or regenerate neurons lost to Alzheimer's disease, the most common type of dementia. Existing treatments can slow disease progression but do not reverse cognitive decline. In a study publishing in the Cell Press journal Cell Biomaterials on August 26, researchers show that engineered nanoparticles can not only regenerate neurons in human brain organoids but also restore neural circuits and improve cognition in mice. 

    The new neurons can become mature and survive. We also confirmed much higher neuron density in the brains of treated mice." 

    Peisheng Xu, corresponding author, professor of pharmaceutics, University of South Carolina

    Xu's team studied a polymer nanogel system called Nano-ERASER that uses antibodies to degrade targeted proteins. They used the system to permeate the blood-brain barrier and enter astrocytes, which are star-shaped support cells abundant in the central nervous system. Within the astrocytes, Nano-ERASER deployed antibodies to break down a protein called PTBP1, triggering the astrocytes to convert to neurons. 

    Compared to gene-editing tools like CRISPR, Nano-ERASER does not modify DNA and its cell reprogramming is reversible. 

    "We hope this can be more effective and also safer," Xu says. "We don't need to worry about the potential side effects caused on the genetic level." 

    First, the researchers applied Nano-ERASER to human astrocyte cultures, as well as human organoids designed to mimic brains with Alzheimer's disease. In both models, PTBP1 levels were reduced, prompting the conversion of astrocytes to neurons. Further testing revealed these new neurons were functional. 

    Next, the team treated mice with Alzheimer's disease. Over several weeks, their nesting skills recovered, and they completed a water maze more efficiently than before, suggesting improved learning and memory. In addition, the mouse brains showed increased neuron density and reduced neuroinflammation and amyloid-beta protein buildup, a hallmark of Alzheimer's disease. 

    "After just two injections, these mice became smarter," Xu says. "Even after one injection, we already saw these mice's behavior differ from that of the nontreated ones." 

    The findings mark a critical step in regenerative neuroscience, Xu says, in part because previous research has debated whether PTBP1 suppression alone could induce in vivo neuroregeneration. 

    Though this study does not prove that Nano-ERASER treats Alzheimer's disease in humans, Xu says it offers a roadmap for a potential cure. He and his colleagues plan to evaluate the platform for longer-term efficacy, test it in nonhuman primates, and one day begin human clinical trials. 

    "If we can advance it to the clinic, then we can have hope for patients with Alzheimer's disease," Xu says. 

    Source:
    Journal reference:

    Wang, M., et al. (2026). Reverse the progression of Alzheimer’s disease through Nano-ERASER-based adult neuroregeneration. Cell Biomaterials. DOI: 10.1016/j.celbio.2026.100575. https://www.cell.com/cell-biomaterials/fulltext/S3050-5623(26)00231-X

    Coffee’s link to Parkinson’s risk may depend on how your body handles caffeine

    No clue on what this is saying.

    Will your incompetent? doctor and hospital ever come around to a 24 hour coffee station? Or are they mired in ignorance and absolute stupidity?

    How coffee protects against Parkinson’s Aug. 2014 

    Coffee May Lower Your Risk of Dementia Feb. 2013

    Coffee drinkers rejoice! Drinking coffee could lower the risk of Alzheimer’s disease 

    And this: Coffee's Phenylindanes Fight Alzheimer's Plaque December 2018

    New research suggests drinking coffee may reduce the risk of frailty May 2025

    I think I'm in this category:  I never get the jitters or flushed skin.

    Genetics determine how much coffee you can drink before it goes wrong

    I'm doing a 12 cup pot of coffee a day with full fat milk to lessen my chances of dementia and Parkinsons. Tell me EXACTLY how much coffee to drink for that and I'll change. Yep, that is a lot more than the 400mg. suggested limit, I don't care! Preventing dementia and Parkinsons is vastly more important than whatever problems it can cause! 

    Of course, your fuckingly incompetent? doctor did nothing with this from 3+ years ago! And still hasn't created a 24 hour coffee station

    Dementia risk could drop by drinking just one shot daily of common beverage  August 2023

    This line is great: The findings indicate that even the Espresso Martini cocktail contains the espresso's beneficial compounds - and can contribute to staving off dementia.

    The latest here: 

     Coffee’s link to Parkinson’s risk may depend on how your body handles caffeine

    Why does coffee appear to have different links with Parkinson’s risk from one person to another? A study of more than 435,000 people points to the interplay between caffeine metabolism, genetics, and sex.

    Study: Coffee and Parkinson’s disease: associations by CYP1A2 genotype and sex in UK Biobank. Image Credit: Valery Evlakhov / Shutterstock

    In a recent study published in the journal npj Parkinson's disease, researchers investigated whether the cytochrome P450 1A2 (CYP1A2) genotype and sex modify the association between Parkinson's disease (PD) and coffee consumption.

    PD is a progressive neurodegenerative condition that manifests with non-motor and motor symptoms, which impair the quality of life. While the etiology of PD is elusive, most cases (> 90%) result from the interplay between environmental exposures and genetic susceptibility. Organic solvents, heavy metals, and pesticides have been linked to a higher risk of PD, whereas caffeine intake has been associated with reduced risk.

    Sex differences are also well recognized, with males exhibiting two-fold higher PD incidence than females, and females showing faster disease progression and higher mortality. Epidemiological studies consistently indicate an association between coffee intake and lower PD incidence, an association thought to be driven largely by caffeine, as decaffeinated coffee has not shown comparable benefits. However, not all people benefit equally from caffeine intake, suggesting inter-individual differences.

    CYP1A2 is the main enzyme involved in caffeine metabolism. A genetic variant of CYP1A2, rs762551, alters inducibility: AA carriers are classified as fast metabolizers, AC carriers as intermediate metabolizers, and CC carriers as slow metabolizers, with slower metabolism resulting in prolonged systemic exposure to caffeine. Nevertheless, studies have yielded inconsistent results regarding caffeine–gene interactions, with some finding inverse associations in slow metabolizers and others reporting none.

    About the study

    In the present study, researchers evaluated how sex and the CYP1A2 genotype modify the association between PD and coffee consumption. They used data from the United Kingdom Biobank (UKB), a prospective cohort study of over half a million participants aged 37–73 years. At baseline, subjects completed questionnaires, underwent physical examinations, and provided blood, urine, and saliva samples.

    Coffee consumption was determined from baseline questionnaires. Genotyping was performed using two genome-wide arrays. The primary exposure was the CYP1A2 rs762551 polymorphism. Participants were classified by genotype: AA carriers (fast metabolizers), AC carriers (intermediate metabolizers), and CC carriers (slow metabolizers). The primary outcome was PD incidence, determined from linked hospital and healthcare records.

    Kaplan-Meier survival curves were used to illustrate the cumulative incidence of PD across CYP1A2 genotypes and coffee intake categories (0 cups/day, <5 cups/day, and ≥5 cups/day). Cox proportional hazards regression was used to assess the association between coffee intake and PD risk. Effect modification by CYP1A2 genotype and sex was investigated. Restricted cubic spline analyses examined potential non-linear dose-response relationships.

    Findings

    The study included 435,551 UKB participants free of PD at baseline. Most participants were White (>94%), and CYP1A2 genotypes were similarly distributed across coffee intake categories. Among these, 3,319 individuals developed PD during a median of 15.7 years of follow-up. Individuals with higher coffee intake (≥ five cups/day) had more frequent alcohol consumption, higher rates of current smoking, and lower tea intake. In the overall analysis, no significant associations were observed between the CYP1A2 genotype or coffee intake and PD risk.

    Survival curves also revealed no significant differences in PD incidence across CYP1A2 genotypes or coffee intake categories. Nevertheless, there was a significant interaction between the CYP1A2 genotype and coffee consumption, indicating that the association varied by genotype. That is, AA carriers had a significantly reduced PD risk with low-to-moderate coffee consumption, an effect not observed at high intake levels.

    AC carriers had a significant increase in PD risk with higher coffee intake; CC carriers also showed an increased risk. AA carriers exhibited a non-linear association, with the lowest risk of PD at about three cups/day of coffee intake. CC or AC carriers showed no significant non-linearity. Furthermore, stratified analyses by genotype and sex revealed that female AA carriers consuming < five cups/day had a lower PD risk, whereas male AC or CC carriers had an increased risk with high intake. However, formal interaction tests involving sex were not statistically significant, so these sex-specific patterns should be interpreted cautiously.

    The genotype-specific patterns were broadly maintained across sensitivity analyses that excluded early PD cases, used alternative coffee-intake categories, adjusted more extensively for smoking, and tested different genotype groupings.

    Conclusions

    In summary, the association between coffee intake and PD risk varied by CYP1A2 genotype. There was a lower risk of PD among AA carriers who reported low-to-moderate coffee consumption, with the pattern most evident in females, but an increased risk among CC or AC carriers, particularly in males, with higher intake. However, coffee consumption was self-reported only at baseline and included both caffeinated and decaffeinated coffee, meaning the findings cannot be interpreted as evidence of a caffeine-specific effect.

    The predominantly White European cohort and relatively small numbers of PD cases in some genotype–intake groups, particularly CC carriers, also limit the precision and generalizability of the subgroup findings. As an observational study, the research does not establish causality or support changing coffee consumption based on CYP1A2 genotype; instead, it provides hypotheses for future genotype-informed epidemiological and interventional studies.

    Journal reference: